Kunlun Capital logo

Kunlun Capital

Asia, Central Region, Singapore, Singapore

Description

Kunlun Capital is an investment firm.

Investor Profile

Kunlun Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series D, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Consumer Goods, E-Commerce, Food and Beverage.

Stage Focus

  • Series A (50%)
  • Series D (25%)
  • Post Ipo Equity (25%)

Country Focus

  • China (100%)

Industry Focus

  • Consumer Goods
  • E-commerce
  • Food And Beverage
  • Warehousing
  • Health Care
  • Product Research
  • Artificial Intelligence (Ai)
  • Blockchain
  • Computer
  • Finance
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kunlun Capital frequently co-invest with?

D. E. Shaw & Co.
North America, New York, United States, New York
Co-Investments: 1
Alibaba Group
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Anatole
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Dragoneer Investment Group
North America, California, United States, San Francisco
Co-Investments: 1
DST Global
Europe, England, United Kingdom, London
Co-Investments: 1
Cygnus Equity
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
FC
North America, Arizona, United States, Scottsdale
Co-Investments: 1
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Jeneration Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by Kunlun Capital?

Ningbo Shanshan

Ningbo, Zhejiang, China

Ningbo Shanshan is a energy industry.

BatteryChemicalManufacturing
Post Ipo EquityApr 19, 2022
Amount Raised: $477,047,001
Nutshell Therapeutics

Huangpu, Shanghai, China

Nutshell Therapeutics invents small molecules in the realm of drug discovery fostered by protein dynamics.

Health CareProduct Research
Series AMar 14, 2022
Amount Raised: $40,000,000
YUSUR Technology

Haidian, Beijing, China

YUSUR Technologyis a DPU chip company that specializes in the development of dedicated computing architectures.

Artificial Intelligence (AI)BlockchainComputerFinance
Series ADec 21, 2021
Nice Tuan

Beijing, Beijing, China

Nice Tuan is an e-commerce platform that provides fresh produce, beverage, leisure food, and daily supplies.

Consumer GoodsE-CommerceFood and BeverageWarehousing
Series DMar 31, 2021
Amount Raised: $750,000,000